click below
click below
Normal Size Small Size show me how
Chap. - 24
PharmacologyHSC1149
Question | Answer |
---|---|
Contains the same dose of Estrogen and Progestin for 3 weeks and 1 week of inert pills (no hormone) | monophasic combination oral contraceptives |
Contains the same doses of Estrogen and Progestin which varies at 1 week intervals for a total of 3 weeks and 1 week of inert pills (no hormone) | Triphasic Combination Oral Contraceptives |
Contains progesterone only which effects the function of uterine endometrium | Progestin IUD |
Contains high doses of estrogen intended to be taken all in one day | Emergency Contraceptive Kit |
Contains both estrogen and progestin which are absorbed in high levels by transdermal route | Estrogen Transdermal Patch |
places women at risk for hemorrhage during labor, delivery, & postpartum | oxcytocin induction |
emergency contraceptive kit has been approved by FDA for __ purchase | OTC |
high risk of thromboembolism & strokes in women over 35 who smoke | estrogen preparations |
usually used as bronchodilator but can also be used to treat preterm labor | terbutaline |
risk for severe hypotension especially if taken with nitroglycerin for angina | sildenafil (Viagra) |
must be closely monitored for risk of resp. paralysis that may be fatal | magnesium sulfate |
chemical substances that originate within different areas of body that regulate functions of reproductive systems | endogenous |
secreted by anterior & posterior pituitary lobes | gonadotropins |
include: FSH, LH, & LTH | gonadotropic hormones |
stimulates development of ovarian follicles in female & sperm production in testes of male | follicle-stimulating hormone (FSH) |
works in conjunction w/FSH to induce secretion of estrogen, ovulation, & development of corpus luteum | luteinizing hormone (LH) |
stimulates secretion of progesterone by corpus luteum & secretion of milk by mammary gland | luteotropic hormone (LTH) |
LTH is termed | lactogenic hormone |
male hormones; secreted mainly in interstitial tissues of testes & secondarily in adrenal glands of both sexes | androgens |
stimulate development of male characteristics | testosterone & andosterone |
male hormone; medication used for replacement therapy and other uses | testosterone |
may be due to: pituitary malfunction/atrophy, injury to/removal of testes/castration which results in eunuchism or eunuchoidism | inadequate production of androgens |
include: retarded development of sex organs, absence of body hair/beard, high-pitched voice, & lack of muscular development | eunuchoid characteristics |
may also result in impotence/deficient sperm production | hypogonadism |
deficient sperm production | oligospermia |
use of androgens in cases of diminished testicular hormone | testosterone replacement |
a condition in which one or both testes fail to descend normally | cryptorchidism |
cryptorchidism or delayed puberty in the male are considered | congenital hypogonadism |
inflammation of a testis | orchitis |
orchitis, trauma, tumor, radiation, surgery of testicles or drug-induced are considered | acquired hypogonadism |
androgens can be used for __ treatment of females w/advance metastatic (skeletal) carcinoma of breast | palliative |
androgen used in treatment of advance metastatic (skeletal) carcinoma of breast in the female | methyltestosterone |
androgen used in treatment of endometriosis & fibrocystic breast disease | danazol |
indicated for side effect of edema w/androgens | diuretics |
acne, increased oiliness of skin/hair, or alopecia; jaundice & hepatitis; premature closure of bone ends in adolescents w/stunting of growth are all | side effects of androgens |
side effects of __ __ __ can include increased LDL, decreased HDL, & insulin resistance | androgen drug therapy |
patients being treated w/androgen who have cardiac, renal & liver dysfunctions may experience | edema |
for geriatric males being treated w/androgens may have an increased risk of __ __ and carcinoma or over-stimulation sexually | prostatic hypertrophy |
patients who are diabetic, obese, or dyslipidemia androgens are | contraindicated |
androgens can cause interactions w/ __ __, potentiation may cause bleeding | oral anticoagulants |
androgens can cause interactions w/ diabetic medication caused decreased blood glucose & decreased | insulin requirements |
antiandrogens that interact with androgens are | dutasteride & finasteride |
illegal use of anabolic steroids can have potentially serious adverse effects of the development of __ with delusions, paranoia, depression, mania & aggression w/violence | psychosis |
due to an increased cancer risk, the FDA (but not approved) warned 23 companies to stop manufacturing, marketing, & distributing | Andro, Androstene (androstenedione) |
all androgen agents are classified as a __ __ (C-III) by DEA due to abuse potential | controlled substance |
sexual side effects that females can experience from androgens include | hirsutism & voice deepening |
excessive growth of hair of normal or abnormal distribution | hirsutism |
class of drug given orally for treatment of male erectile dysfunction (ED)/impotence | phosphodiesterase (PDE) inhibitors |
first PDE inhibitor approved by FDA to treat ED | sildenafil (Viagra) |
other PDE inhibitor(s) approved by FDA to treat ED | vardenafil (Levitra) & tadalafil (Cialis) |
side effects include: headache, flushing, abnormal vision, dizziness; dyspepsia, nasal congestion, rhinitis, diarrhea, rash; cardio events incl angina, syncope, tachycardia, palpitation, & hypotension | PDE inhibitors |
concurrent use of nitrates or alpha-blockers is contraindicated because use with PDE inhibitors potentiates | hypotensive effects |
a contraindication of PDE inhibitors includes erections lasting >4h; resulting in tissue damage & __ loss of potency | permanent |
PDE inhibitors are contraindicated for older adults and patient w/preexisting | cardiovascular risk factors |
PDE inhibitors are contraindicated for patients with __ or __ function impairment | hepatic; renal |
nitrates, antiretroviral protease inhibitors, macrolides, & some antifungals interact w/PDE inhibitors by | prolonging hypotensive effects |
PDE inhibitors should not be taken concurrently with __ __, potentiates hypotensive effects | grapefruit juice |
female sex hormones; produced mainly by ovary & secondarily by adrenal glands; responsible for development of female secondary characteristics | estrogens |
during menstrual cycle estrogens act on female genitalis to produce environment suitable for | fertilization, implantation, & nutrition of early embryo |
estrogens affect secretion of FSH & LH from anterior pituitary by inhibiting | lactation & ovulation |
sometimes used in management of severe menopausal symptoms that do not respond to one hormone alone | estrogen & testosterone |
associated w/increased risk of endometrial carcinoma in women w/intact uterus | estrogen therapy (ET) |
when __ is combined with estrogen, the risk of endometrial cancer is substantially reduced | progestin |
progestin & estrogen is | combined hormone therapy (HT) |
main thrust of __ __ was to determine the exact degree to which HTs presumably protect heart & degree to which some of the potential risks of HTs canceled out | WHI study |
WHI study also explored whether HTs __ fractures, colon cancer, & dementia incl. Alzheimer's disease | prevented |
WHI study announced the risks of combined HTs __ its benefits when used to prevent certain diseases | outweighed |
WHI study announced the risks of combined HTs could actually __ __ of certain conditions it was being used to prevent | increase risk |
ACOG recommendations state __ __ should not be used for prevention of diseases, such as cardiovascular disease, due to small/significant increased risk of breast cancer, heart attack, stroke, & blood clots | combined HT |
ACOG recommendations state that should not be used for women who have had a hysterectomy for the prevention of diseases, due to increased risk of blood clots & stroke | estrogen-alone therapy |
ACOG recommendations state that women w/a uterus should not use estrogen alone due to increased risk of __ cancer | uterine |
ACOG recommendations state that HTs are appropriate for relief of | vasomotor symptoms |
ACOG recommendations state that women in combined HT or ET should take __ __ __ for shortest possible time & annually review decision to take hormones | smallest effective dose |
women who use the patch contraceptives may __ risks for blood clots | reduce |
blood clot risk for oral contraceptives may be higher due to the pills being broken down in the liver, where __ involved in formation of blood clots are activated | proteins |
estrogens in skin patches are released directly into the bloodstream bypassing the | liver completely |
used for treatment of endometriosis, fibrocystic breast disease; trade name for danazol | Danocrine |
androgen agent used for treatment of anemia of renal disease | nandrolone |
androgen agent used for treatment of cachexia; trade name for oxandrolone | Oxandrin |
androgen agent used for treatment of hypogonadism, advanced breast cancer; trade name for testosterone | Depo-Testosterone, Testoderm, Androderm, AndroGel |
androgen agent used for treatment of menopausal symptoms if estrogen insufficient alone; trade name for testosterone/estrogen | Estratest |
impotence agent used for treatment of erectile dysfunction, but no effect in absence of sexual stimulation; trade name for sildenafil | Viagra |
impotence agent used for treatment of erectile dysfunction, but no effect in absence of sexual stimulation; trade name for tadalafil | Cialis |
impotence agent used for treatment of erectile dysfunction, but no effect in absence of sexual stimulation; trade name for vardenafil | Levitra |
contraceptives used to treat menstrual irregularities & dysmenorrhea | estrogen & progestin combination |
ET used to treat menopausal mild-moderate depression only is unable/unwilling to take | SSRIs |
ET used to treat female hypogonadism due to __ pathology or oophorectomy | ovarian |
ET used to treat postmenopausal prevention of osteoporosis only if __ to take other agents, or if benefits outweigh risks | unable |
ET used to treat postmenopausal to reduce __ disease & elevate the HDL in women (conflicting studies | cardiovascular |
ET used to treat __ __ from decreased secretions, in a low-dose vaginal cream | atrophic vaginitis |
ET used to treat __ after rape or incest (within 24-48h) in a single large dose to prevent, not terminate, pregnancy | postcoital |
ET used in palliative treatment for males with advanced, inoperable | prostate cancer |
hormone secreted by corpus luteum & adrenal glands; resp. for changes in uterine endometrium in 2nd 1/2 of menstrual cycle in prep from implantation of fertilized ovum, devel. maternal placenta after implantation, & devel. mammary glands | progesterone |
synthetic drugs that exert progesterone-like activity | progestins |
incl: irregular menses & amenorrhea, breakthrough bleeding/spotting; edema/weight gain; thromboembolic disorders | side effects of progestins |
progestins are contraindicated for women who are pregnant because of potential adverse effects on | the fetus |
progestins are contraindicated for breast, cervical, uterine, & vaginal cancer treatment except for | palliative treatment |
estrogen used in treatment of menopause, prostate cancer, breast cancer, dysfunctional uterine bleeding; trade name for estradiol | Estrace |
estrogen used in treatment of menopause only; trade name for estradiol | Estrasorb, Estro Gel, Estraderm, Vivelle, Depo-Estradiol |
estrogen used in treatment of female hypogonadism, breast engorgement, prostate cancer, menopausal sx; trade name for conjugated estrogens | Premarin |
estrogen used in treatment of female hypogonadism, menopausal symptoms; dysfunctional uterine bleeding; trade name for esterified estrogens | Estratab, Ogen |
progestins used in treatment of abnormal uterine bleeding, menopausal symptoms, contraception; trade name for medroxyprogesterone | Provera, Depo-Provera |
progestins used in treatment of endometrial & breast cancer, anorexia, & cachexia of AIDS; trade name for megestrol acetate | Megace |
combinations used in treatment for menopausal symptoms, female hypogonadism; trade name for conjugated estrogens/medroxyprogesterone | Premphase, Prempro |
combinations used in treatment for menopausal symptoms; trade name for estradiol/norethindrone | CombiPatch |
estrogen contraceptive monophasic preparations containing same proportion of estrogen & progesterone in each tablet 50mcg | Ovral, Ovcon-50, |
estrogen contraceptive monophasic preparations containing same proportion of estrogen & progesterone in each tablet 35mcg | Norinyl I/50 & I/35, Brevicon, Ortho-Cyclen |
estrogen contraceptive monophasic preparations containing same proportion of estrogen & progesterone in each tablet 30mcg | Lo-Ovral, Loestrin, Yasmin |
estrogen contraceptive monophasic preparations containing same proportion of estrogen & progesterone in each tablet 20mcg | Loestrin |
estrogen contraceptive monophasic preparation; 20mcg estrogen patch | Ortho Evra |
Biphasic prep; 2 sequences progestin, 1 part estrogen; 35 mcg estrogen | Ortho Novum 10/11, Neocon 10/11 |
triphasic prep; 3 sequences progestin, 1 part estrogen; dose varies | Seasonale/Triphasil, Ortho Novum 7/7/7, Tri-Cyclen |
progestin-only prep; PO | Micronor/Ovrette |
progestin-only prep; IM | Depo-Provera |
progestin-only prep; IUD | Mirena |
postcoital contraception; PO must be administered within 72h | Ovral |
postcoital contraception; estrogen/progestin; emergency contraceptive kit | Preven |
postcoital contraception; mifepristone RU486; PO 600 mg once then 2 days later misoprostol 400mg; must follow protocol carefully | Mifeprex |
medication used in management of pre-term labor | terbutaline (Brethine) |
medication used to induce labor by causing uterus to contract | oxytocin |
chorionic gonadotropin (Prosafil) is used to induce ovulation in women who have been treated with | menotropins |
pregnant women should avoid taking estrogen because it can cause serious fetal | toxicity |
oxytocics³; administration PO or IM dosage varies; used to treat postpartum hemorrhage; trade name for methylergonovine | Methergine |
oxytocics³; administration IV or nasal spray; used for labor induction & postpartum hemorrhage; trade name for oxytocin | Pitocin |
prostaglandins; administration vaginal suppository 20mg; used for therapuetic abortion; trade name for dinoprostone | Prostin E₂ |
prostaglandins; administration vaginal insert; used for cervical ripening; trade name for dinoprostone | Cervidil |
prostaglandins; administration intravaginal gel; used for cervical ripening; trade name for dinoprostone | Prepidil |
prostaglandins; administration tablets; used for pregnancy termination; trade name for misoprostol | Cytotec |
adrenergicsь; administration IV or PO dose varies; used for premature labor; trade name for terbutaline | Brethine |
treatment for preeclampsia/eclampsia; IM or IV dose varies; watch for respiratory complications | magnesium sulfate |
gonadotropic associated; administration nasal spray, dose varies; used for endometriosis (treatment not to exceed 6months); trade name for nafarelin acetate | Synarel |
gonadotropic associated; administration IM, dose varies; used for endometriosis, some cases infertility (treatment not to exceed 6months) & prostate cancer (antineoplastic); trade name for leuprolide acetate | Lupron Depot |
gonadotropic associated; administration PO, dose varies; used for infertility treatment, ovulation induction; trade name for clomiphene citrate | Clomid, Seraphene |
gonadotropic associated; administration IM daily for 7-12days; used for infertility treatment, stimulates follicle development; trade name for menotropins | Repronex |
gonadotropic associated; administration IM single dose, 5-10,000 units; used for infertility treatment, given 1 day after Repronex, to induce ovulation; trade name for chorionic gonadotropin (CG) | Profasi, Pregnyl |
gonadotropic associated; administration subQ, IM daily for 7-12 days; used for induction of ovulation in women w/polycystic ovaries followed w/injection of CG; trade name for urofollitropin | Bravelle |